New Method Tracks the 'Learning Curve' of AI to Decode Complex Genomic Data

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain vast amounts of annotated samples, but many of these samples are annotated either incorrectly or ambiguously. Borrowing from recent advances in the fields of natural language processing and computer vision, the team used artificial neural networks (ANNs) in a non-conventional way: instead of merely using the ANNs to make predictions, the group inspected the difficulty with which they learned to label different biological samples. Somewhat similarly to assessing why students find some examples harder than others, the team then leveraged this unique source of information to identify mismatches in cell annotations, improve data interpretation, and uncover key cellular pathways linked to development and disease. Annotatability provides a more accurate method for analyzing genomic data on single cells, offering significant potential for advancing biological research, and in the longer term, improving disease diagnosis and treatment.

A new study led by Jonathan Karin, Reshef Mintz, Dr. Barak Raveh and Dr. Mor Nitzan from Hebrew University, published in Nature Computational Science, introduces a new framework for interpreting single-cell and spatial omics data by monitoring deep neural networks training dynamics. The research aims to address the inherent ambiguities in cell annotations and offers a novel approach for understanding complex biological data.

Single-cell and spatial omics data have transformed our ability to explore cellular diversity and cellular behaviors in health and disease. However, the interpretation of these high-dimensional datasets is challenging, primarily due to the difficulty of assigning discrete and accurate annotations, such as cell types or states, to heterogeneous cell populations. These annotations are often subjective, noisy, and incomplete, making it difficult to extract meaningful insights from the data.

The researchers developed a new framework, Annotatability, which helps identify mismatches in cell annotations and better characterizes biological data structures. By monitoring the dynamics and difficulty of training a deep neural network over annotated data, Annotatability identifies areas where cell annotations are ambiguous or erroneous. The approach also highlights intermediate cell states and the complex, continuous nature of cellular development.

As part of the study, the team introduced a signal-aware graph embedding method that enables more precise downstream analysis of biological signals. This technique captures cellular communities associated with target signals and facilitates the exploration of cellular heterogeneity, developmental pathways, and disease trajectories.

The study demonstrates the applicability of Annotatability across a range of single-cell RNA sequencing and spatial omics datasets. Notable findings include the identification of erroneous annotations, delineation of developmental and disease-related cell states, and better characterization of cellular heterogeneity. The results highlight the potential of this framework for unraveling complex cellular behaviors and advancing our understanding of both health and disease at the single-cell level.

The researchers' work presents a significant step forward in genomic data interpretation, offering a powerful tool for unraveling cellular diversity and enhancing our ability to study the dynamics of health and disease.

Karin J, Mintz R, Raveh B, Nitzan M.
Interpreting single-cell and spatial omics data using deep neural network training dynamics.
Nat Comput Sci. 2024 Dec;4(12):941-954. doi: 10.1038/s43588-024-00721-5

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...